Gastrointestinal Cancer News

Cancer death rates declined broadly between 2015 and 2019 in the United States as overall incidence remained generally stable, according to the Annual Report to the Nation on the Status of Cancer.

The FDA granted fast track designation to ITM-11 for treatment of gastroenteropancreatic neuroendocrine tumors.

CHARLOTTE, N.C. — Although 20% of patients with young-onset colorectal cancer have pathogenic germline variants, less than two-thirds receive referrals for genetic counseling, according to a data from the ACG Annual Scientific Meeting.

An artificial intelligence model appeared to predict the likelihood of unplanned hospitalizations during chemoradiation therapy among a cohort of patients with various cancer types.

CHARLOTTE, N.C. — High-quality index colonoscopy decreased the risk for advanced long-term outcomes among New Hampshire residents with no adenomas or significant serrated polyps, according to research at the ACG Annual Scientific Meeting.

The addition of stereotactic body radiation therapy to sorafenib extended OS among patients with advanced hepatocellular carcinoma, results of the randomized phase 3 NRG Oncology/RTOG 1112 trial showed.

The FDA approved tremelimumab in combination with durvalumab for adults with unresectable hepatocellular carcinoma.

GENEVA — A large percentage of people with colorectal cancer around the world are diagnosed through emergency presentation, according to study results presented at World Cancer Congress.

GENEVA — A validated prediction model showed the potential to identify people at greater risk for high-grade intraepithelial neoplasia or esophageal cancer, according to study results presented at World Cancer Congress.

GENEVA — Exposure to proton pump inhibitors appeared associated with increased risk for certain cancers, according to results of a meta-analysis presented at World Cancer Congress.